Contact Sales
Fill in the form to have a Dassault Systèmes expert contact you to answer your questions and discuss any of your needs or call directly on one of these numbers:
USA & Canada: 1855 696 1125
India: 1800 200 9276
Other English countries: +800 379 78 361
If you have any questions regarding our other services, please get in touch with:
Unify modelling & testing to accelerate the discovery of high-quality novel therapeutics
Contact Sales
Fill in the form to have a Dassault Systèmes expert contact you to answer your questions and discuss any of your needs or call directly on one of these numbers:
USA & Canada: 1855 696 1125
India: 1800 200 9276
Other English countries: +800 379 78 361
If you have any questions regarding our other services, please get in touch with:
Pharmaceutical and Biotechnology companies are challenged with the increasing need to streamline the discovery stage and drive down costs while reducing time to market with higher quality, novel therapeutics. These expectations create a number of critical business challenges for BioPharmaceutical companies.
The Designed to Cure solution delivers a holistic drug discovery experience that inspires collaboration and facilitates the exchange of scientific results to swiftly advance the best candidates to clinical trials. Robust, predictive analytics tools that leverage existing experimental results rapidly optimize therapeutic efficacy and safety and deliver predictions of potential downstream manufacturing issues to guarantee rapid formulation of efficacious, stable therapeutics and speed up time to market.
Getting to Market Faster With Higher Quality Novel Therapeutics
Life Sciences laboratories face many challenges in getting quality candidates to market: disconnected systems, difficulty coordinating external teams, challenges in identifying viable candidates and costly failures – all of these inefficiencies reduce productivity to a crawl. Watch our Webinar to learn how to overcome these challenges.
Synchronize and enhance collaboration using integrated systems that provide high quality, accessible scientific knowledge across the organization and research sites.
Take better informed decisions to the pipeline thanks to advanced dashboarding and data-driven analysis
Accelerate drug design and development by combining in silico such as molecular modelling and physical experiments.
Integrate Quality-by-Design principles early in the Discovery Research phase to reduce the time to develop new therapeutics and stay ahead of the competition.
With increasing operational costs, and high development failure rates resulting in fewer, lesser quality candidates entering clinical phases, the pressure is on to deliver better results that can drive down costs while reducing time-to-market. Designed to Cure enables collaborative, knowledge-driven innovation, and predictive analytics along with virtual design to enable higher quality candidates to get to market faster.
Contact Sales
Fill in the form to have a Dassault Systèmes expert contact you to answer your questions and discuss any of your needs or call directly on one of these numbers:
USA & Canada: 1855 696 1125
India: 1800 200 9276
Other English countries: +800 379 78 361
If you have any questions regarding our other services, please get in touch with:
Get a Quote
Fill in the form to have a Dassault Systèmes sales contact you to provide you with a quote that suits with your requirements or call directly one of these numbers:
USA & Canada: 1855 696 1125
India: 1800 200 9276
Other English countries: +800 379 78 361
If you have any questions regarding our other services, please get in touch with:
The Predictive Sciences Program at Merck is a comprehensive package of data access, aggregation, predictive modeling, and advanced analytics that will transform productivity and inform the research and development decision making processes. This capability will allow scientists to use enhanced judgment resulting in reduced attrition and cycle time and increased Merck research and development pipeline productivity
Designed to Cure enables therapeutic delivery, the prediction of critical design and manufacturability characteristics and delivers an integrated, comprehensive and rational drug development approach through virtual design, collaboration and knowledge driven innovation.